{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:05:03Z","timestamp":1776276303913,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.cllc.2018.05.017","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T08:12:58Z","timestamp":1528186378000},"page":"467-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non\u2013Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis"],"prefix":"10.1016","volume":"19","author":[{"given":"Zachary","family":"Schlei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark G.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace K.","family":"Dy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"68","key":"10.1016\/j.cllc.2018.05.017_bib1","first-page":"7","article-title":"Cancer statistics, 2018","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2018.05.017_bib2","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.cllc.2018.05.017_bib3","series-title":"Pemetrexed [package insert]","year":"2004"},{"issue":"suppl3","key":"10.1016\/j.cllc.2018.05.017_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/bjc.1998.752","article-title":"Clinical studies with MTA","volume":"78","author":"Calvert","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2018.05.017_bib5","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S0169-5002(01)00396-8","article-title":"Alimta\u00ae (pemetrexed disodium, LY231514, MTA): clinical experience in non\u2013small cell lung cancer","volume":"34","author":"Novello","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2018.05.017_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1008336931378","article-title":"Front-line treatment of advanced non\u2013small-cell lung cancer with MTA (LY231514, pemetrexed disodium, Alimta\u2122) and cisplatin: a multicenter phase II trial","volume":"11","author":"Mangold","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2018.05.017_bib7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1023\/A:1008379101017","article-title":"Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors","volume":"11","author":"Adjei","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2018.05.017_bib8","first-page":"545","article-title":"Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy","volume":"1","author":"Niyikiza","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cllc.2018.05.017_bib9","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.05.017_bib10","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.2003.06.122","article-title":"Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma","volume":"21","author":"Scagliotti","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.05.017_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/TCRM.S1603","article-title":"Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma","volume":"4","author":"Goudar","year":"2008","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.cllc.2018.05.017_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000353573","article-title":"Are 5-7 days of folic acid supplementation necessary prior to pemetrexed? Observations from a case series","volume":"6","author":"Griffin","year":"2013","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.cllc.2018.05.017_bib13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1634\/theoncologist.2014-0221","article-title":"A\u00a0prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non\u2013small cell lung cancer","volume":"19","author":"Tagaki","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.cllc.2018.05.017_bib14","first-page":"487","article-title":"A\u00a0clinical study on the absorption, distribution and excretion of radioactive vitamin B12","volume":"80","author":"Kawamura","year":"1971","journal-title":"J\u00a0Juzen Med Soc"},{"key":"10.1016\/j.cllc.2018.05.017_bib15","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/JTO.0b013e3181898e32","article-title":"Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial","volume":"3","author":"Socinski","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"issue":"suppl 2","key":"10.1016\/j.cllc.2018.05.017_bib16","doi-asserted-by":"crossref","first-page":"S1807","DOI":"10.1016\/j.jtho.2017.09.461","article-title":"Timing of B12\/folate supplementation in NSCLC patients on pemetrexed based chemotherapy: final results of the PEMVITASTART randomized trial (NCT02679443)","volume":"12","author":"Singh","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2018.05.017_bib17","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1200\/JCO.2004.03.121","article-title":"Complementary and alternative medicine use by patients enrolled onto phase I clinical trials","volume":"22","author":"Dy","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.05.017_bib18","first-page":"2465","article-title":"Does perceived control predict complementary and alternative medicine (CAM) use among patients with lung cancer? A cross-sectional survey","volume":"22","author":"Baumi","year":"2014","journal-title":"Support Care Cancer"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730418301372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730418301372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:08:22Z","timestamp":1761505702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730418301372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1525730418301372"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2018.05.017","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non\u2013Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2018.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}